Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 21, 2025

ADRENAL AWARENESS MONTH: Spotlight on Cushing Syndrome and the Hidden Epidemic of Adrenal Disorders

ADRENAL AWARENESS MONTH: Spotlight on Cushing Syndrome and the Hidden Epidemic of Adrenal Disorders

Carling Adrenal Center and Any Lab Test Now Partner to Expand Access to Testing Nationwide TAMPA, FL, UNITED STATES, April 21, 2025 /⁨EINPresswire.com⁩/ -- This April marks Adrenal Awareness Month, a time to bring national attention to adrenal gland …

Revolutionizing Atopic Dermatitis 2025 heads to Nashville, delivering cutting-edge insights for dermatology professionals

Revolutionizing Atopic Dermatitis 2025 heads to Nashville, delivering cutting-edge insights for dermatology professionals

NASHVILLE, TN, April 21, 2025 (GLOBE NEWSWIRE) -- Against the backdrop of Music City’s biggest weekend, leading experts and frontline clinicians will gather in downtown Nashville, Tennessee, for one of dermatology’s most impactful educational events of the …

Game-Changing Medical Demonstration Poised to Rewrite Theranos Story

Game-Changing Medical Demonstration Poised to Rewrite Theranos Story

MIAMI BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- In a moment destined to shake the foundation of modern medicine—and perhaps the U.S. justice system—visionary medical innovator Ryan El-Hosseiny is making a bold and unprecedented claim: Elizabeth …

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Resmed Names Salli Schwartz as Chief Investor Relations Officer

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the appointment of Salli Schwartz as Chief Investor Relations …

Lipozem Reviews and Complaints: Is This Triple-BHB Fat Burner the Real Deal or Just Hype? – User Reviews Tested and Verified!

Lipozem Reviews and Complaints: Is This Triple-BHB Fat Burner the Real Deal or Just Hype? – User Reviews Tested and Verified!

Albany, New York, April 21, 2025 (GLOBE NEWSWIRE) -- Lipozem isn’t just another name in the weight loss world—it’s quickly becoming the buzzword for anyone tired of old-school diet struggles in 2025. Let’s face it: the “eat less, work out more” routine is …

The Phoenix ED Device Reviews: At-Home Acoustic Wave Therapy Device!

The Phoenix ED Device Reviews: At-Home Acoustic Wave Therapy Device!

Scottsdale, Arizona, April 21, 2025 (GLOBE NEWSWIRE) -- Erectile dysfunction is a common issue that affects millions of men all around the world. Unfortunately, this disappointment is the last thing a man wants to experience. An unsatisfied partner is the …

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous …

Revive Therapeutics Announces Proposed Shares for Debt Transaction

Revive Therapeutics Announces Proposed Shares for Debt Transaction

TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, …

Pennant Announces First Quarter 2025 Earnings Release and Call

Pennant Announces First Quarter 2025 Earnings Release and Call

EAGLE, Idaho, April 21, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its first quarter …

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

GARDNER, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will be …

Galapagos Announces Executive Leadership Updates

Galapagos Announces Executive Leadership Updates

Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly created SpinCo  Dr. Paul Stoffels, Chair and CEO of Galapagos, plans to retire as CEO upon appointment of successor in the next 12 months and plans to continue as …

Galapagos kondigt wijzigingen aan in uitvoerend leiderschap

Galapagos kondigt wijzigingen aan in uitvoerend leiderschap

De heer Henry Gosebruch benoemd door de Raad van Bestuur van Galapagos als oprichtend CEO van het nieuw opgerichte SpinCo Dr. Paul Stoffels, Voorzitter en CEO van Galapagos, is van plan in pensioen te gaan als CEO na benoeming van een opvolger in de …

Bringing clarity and precision to the cell-free space by introducing exozymes

Bringing clarity and precision to the cell-free space by introducing exozymes

Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of cell-free biomanufacturing—a …

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on …

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …

Clover Health to Participate in Upcoming Investor Conferences

Clover Health to Participate in Upcoming Investor Conferences

WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: CFO, Peter Kuipers, will present at …

Regeneron Announces Investor Conference Presentations

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 13, 2025 2025 …

Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing

Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing

SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced that the Journal of Clinical Psychopharmacology has published a study showing those …

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

CARLSBAD, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2025, before the market opens on Monday, May 5, 2025. John Aballi, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service